Molecular Endocrinology

Journal

Publication Venue For

  • MiR-204 targets PERK and regulates UPR signaling and β-cell apoptosis.  30:917-924. 2016
  • TIMP3 modulates GHR abundance and GH sensitivity.  30:587-599. 2016
  • GHR/PRLR heteromultimer is composed of GHR homodimers and PRLR homodimers.  30:504-517. 2016
  • SSBP3 interacts with islet-1 and ldb1 to impact pancreatic β-cell target genes.  29:1774-1786. 2015
  • Minireview: Directed differentiation and encapsulation of Islet β-cells—Recent advances and future considerations.  29:1388-1399. 2015
  • Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.  28:1841-1854. 2014
  • Dynamic analysis of gh receptor conformational changes by split luciferase complementation.  28:1807-1819. 2014
  • Human gh Receptor-Igf-1 receptor interaction: Implications for gh signaling.  28:1841-1854. 2014
  • Minireview: Thioredoxin-interacting protein: Regulation and function in the pancreatic β-cell.  28:1211-1220. 2014
  • Thioredoxin-interacting protein stimulates its own expression via a positive feedback loop.  28:674-680. 2014
  • IGF-1R modulation of acute GH-induced STAT5 signaling: Role of protein tyrosine phosphatase activity.  27:1969-1979. 2013
  • The Krüppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription.  27:1692-1705. 2013
  • The role of GH in adipose tissue: Lessons from adipose-specific GH receptor gene-disrupted mice.  27:524-535. 2013
  • The role of prolactin receptor in GH signaling in breast cancer cells.  27:266-279. 2013
  • Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.  27:172-184. 2013
  • Research resource: Enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.  26:194-202. 2012
  • Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.  25:2119-2133. 2011
  • cGMP inhibits TGF-β signaling by sequestering Smad3 with cytosolic β2-tubulin in pulmonary artery smooth muscle cells.  25:1794-1803. 2011
  • Growth hormone signaling in human T47D breast cancer cells: Potential role for a growth hormone Receptor-Prolactin receptor complex.  25:597-610. 2011
  • Role of reactive oxygen species in injury-induced insulin resistance.  25:492-502. 2011
  • Hnf1α (MODY3) regulates β-cell-enriched MafA transcription factor expression.  25:339-347. 2011
  • Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.  24:644-656. 2010
  • The osteogenic transcription factor Runx2 controls genes involved in sterol/steroid metabolism, including Cyp11a1 in osteoblasts.  23:849-861. 2009
  • Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.  23:486-496. 2009
  • Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.  22:2532-2543. 2008
  • Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: A novel mechanism for GH insensitivity.  22:1427-1437. 2008
  • Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: Insights into receptor triggering.  22:978-988. 2008
  • Determinants of growth hormone receptor down-regulation.  21:1537-1551. 2007
  • Role of the Growth Hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.  21:1642-1655. 2007
  • Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization.  21:1297-1311. 2007
  • In vivo imaging of hepatic growth hormone signaling.  20:2819-2830. 2006
  • Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes.  20:2539-2547. 2006
  • Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium.  20:1153-1163. 2006
  • Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor.  19:1646-1653. 2005
  • Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance.  19:794-803. 2005
  • 17β-Estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression.  19:113-124. 2005
  • A conformationally sensitive GHR [Growth Hormone (GH) Receptor] antibody: Impact on GH signaling and GHR proteolysis.  18:2981-2996. 2004
  • 17β-estradiol inhibits class ii major histocompatibility complex (MHC) expression: Influence on histone modifications and CBP recruitment to the class II MHC promoter.  18:1963-1974. 2004
  • Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.  18:1471-1485. 2004
  • Prolactin and transforming growth factor-β signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.  18:1171-1184. 2004
  • Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling.  17:2211-2227. 2003
  • Reduced Proteolysis of Rabbit Growth Hormone (GH) Receptor Substituted with Mouse GH Receptor Cleavage Site.  17:1931-1943. 2003
  • Estrogen action via the G protein-coupled receptor, GPR30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.  16:70-84. 2002
  • Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinct.  15:281-293. 2001
  • Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice.  15:600-613. 2001
  • Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.  14:1649-1660. 2000
  • Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development..  11:1766-1781. 1997
  • Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development.  11:1765-1781. 1997
  • Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.  10:1425-1443. 1996
  • TAK1: Molecular cloning and characterization of a new member of the nuclear receptor superfamily.  8:1667-1680. 1994
  • Glucose regulation of transforming growth factor-α expression is mediated by products of the hexosamine biosynthesis pathway.  7:1041-1048. 1993
  • Regulation of transglutaminase type I expression in squamous differentiating rabbit tracheal epithelial cells and human epidermal keratinocytes: Effects of retinoic acid and phorbol esters.  7:387-398. 1993
  • Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation.  6:667-676. 1992
  • Induction of cytoskeletal gene expression by insulin..  6:112-119. 1992
  • Pro-453 to ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.  6:1211-1215. 1992
  • Different isozymes of mouse 11/β-hydroxylase produce mineralocorticoids and glucocorticoids.  5:1853-1861. 1991
  • Transcriptional regulation of the human transforming growth factor-α gene.  5:514-520. 1991
  • Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: Dexamethasone decreases transporter mRNA in primary cultured adipocytes.  3:1132-1141. 1989
  • International Standard Serial Number (issn)

  • 0888-8809
  • Electronic International Standard Serial Number (eissn)

  • 0888-8809
  • 1944-9917